Morgan Stanley (MS)

$MS has released its Q4 2024 earnings, showing a solid EPS of $2.22, beating expectations by $0.54, and revenues of $16.22B, up 25.8% Y/Y, exceeding estimates. Strong financial health is highlighted by a 71.1% efficiency ratio and a 20.2% return on tangible capital. The firm's growth strategy remains robust, with optimism for M&A activity in 2025. However, geopolitical tensions and market fluctuations pose potential risks. For more insights, check the full report at http://valueverge.com/MS.